Pfizer und BioNTech geben Liefervereinbarung mit Kanada für mRNA-basierten Impfstoffkandidaten BNT162 bekannt
05 août 2020 08h00 HE
|
BioNTech SE
Lieferung im Verlauf von 2021, vorbehaltlich der Zulassung durch das kanadische GesundheitsministeriumDie Vereinbarung ist Teil der globalen Bemühungen von Pfizer und BioNTech, die Pandemie zu...
BioNTech und Fosun Pharma beginnen klinische Studie mit mRNA-basiertem COVID-19-Impfstoffkandidaten in China
05 août 2020 04h30 HE
|
BioNTech SE
Phase-1-Studie wird Sicherheit und Immunogenität in chinesischen Probanden evaluieren, um eine potenzielle Zulassung in China zu unterstützenInsgesamt werden 144 Probanden in zwei Altersgruppen in die...
BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China
05 août 2020 04h30 HE
|
BioNTech SE
Phase 1 study will evaluate safety and immunogenicity in Chinese participants to support potential regulatory approval pathway in ChinaTotal of 144 participants to be enrolled in two age groups (18-55...
Innovation Pharmaceuticals and U.S. Regional Biocontainment Laboratory Nearing Completion of Brilacidin Anti-SARS-CoV-2 (COVID-19) In Vitro Testing
04 août 2020 08h00 HE
|
Innovation Pharmaceuticals Inc.
Brilacidin is showing consistent and robust antiviral activity across the viral lifecycle in human lung and Vero cells; potential as a treatment for preventing infection with COVID-19, as well as for...
7 Hills Pharma Awarded Pioneering Patent Estate Covering Integrin Activators to Improve Effectiveness of Immunotherapies
04 août 2020 05h00 HE
|
7 Hills Pharma
HOUSTON, Aug. 04, 2020 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a clinical-stage immunotherapy company focused on the development of drugs for treatment and prevention of cancer and infectious diseases,...
Veterinary Medicine Market to Reach $29.69 Billion by 2027: Allied Market Research
03 août 2020 10h25 HE
|
Allied Market Research
Portland, OR, Aug. 03, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research,the global veterinary medicine market generated $22.97billion in 2019, and is estimated to...
Pfizer und BioNTech geben Liefervereinbarung mit Japan über 120 Millionen Dosen von mRNA-basierten Impfstoffkandidaten BNT162 bekannt
31 juil. 2020 06h41 HE
|
BioNTech SE
Lieferung von 120 Millionen Impfstoffdosen im ersten Halbjahr 2021, vorbehaltlich der behördlichen Genehmigung oder ZulassungDie Vereinbarung ist Teil der globalen Bemühungen von Pfizer und BioNTech,...
Pfizer and BioNTech to Supply Japan with 120 Million Doses of Their BNT162 mRNA-Based Vaccine Candidate
31 juil. 2020 05h15 HE
|
BioNTech SE
Supply of 120 million doses to be provided in the first half of 2021, subject to regulatory approvalAgreement is part of Pfizer’s and BioNTech’s global commitment to help address the pandemicPfizer...
Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study
27 juil. 2020 17h15 HE
|
BioNTech SE
Companies advance nucleoside-modified messenger RNA (modRNA) candidate BNT162b2, which encodes an optimized SARS-CoV-2 full-length spike glycoprotein, at a 30 µg dose level in a 2 dose regimen into...
Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
22 juil. 2020 07h10 HE
|
BioNTech SE; Pfizer Inc.
U. S. government placed an initial order of 100 million doses for $1.95 billion and can acquire up to 500 million additional dosesAmericans to receive the vaccine for free consistent with U.S....